Your browser doesn't support javascript.
loading
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Flinn, Ian W; Gribben, John G; Dyer, Martin J S; Wierda, William; Maris, Michael B; Furman, Richard R; Hillmen, Peter; Rogers, Kerry A; Iyer, Swaminathan Padmanabhan; Quillet-Mary, Anne; Ysebaert, Loic; Walter, Harriet S; Verdugo, Maria; Klein, Christian; Huang, Huang; Jiang, Yanwen; Lozanski, Gerard; Pignataro, Daniela Soriano; Humphrey, Kathryn; Mobasher, Mehrdad; Kipps, Thomas J.
Afiliación
  • Flinn IW; Sarah Cannon Research Institute, Nashville, TN.
  • Gribben JG; Tennessee Oncology, Nashville, TN.
  • Dyer MJS; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
  • Wierda W; Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom.
  • Maris MB; The University of Texas MD Anderson Cancer Center, Houston, TX.
  • Furman RR; Sarah Cannon Research Institute, Colorado Blood Cancer Institute, Denver, CO.
  • Hillmen P; CLL Research Center, Weill Cornell Medicine, New York, NY.
  • Rogers KA; St. James University Hospital, Leeds, United Kingdom.
  • Iyer SP; Division of Hematology, The Ohio State University, Columbus, OH.
  • Quillet-Mary A; Houston Methodist Hospital, Houston, TX.
  • Ysebaert L; Cancer Research Center of Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.
  • Walter HS; Cancer Research Center of Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.
  • Verdugo M; Ernest and Helen Scott Haematological Research Institute, University of Leicester, Leicester, United Kingdom.
  • Klein C; AbbVie, North Chicago, IL.
  • Huang H; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland.
  • Jiang Y; F-Hoffmann-La Roche Ltd, Mississauga, ON, Canada.
  • Lozanski G; Genentech Inc, South San Francisco, CA.
  • Pignataro DS; Department of Pathology, The Ohio State University, Columbus, OH.
  • Humphrey K; Roche Products Limited, Welwyn Garden City, United Kingdom; and.
  • Mobasher M; Roche Products Limited, Welwyn Garden City, United Kingdom; and.
  • Kipps TJ; Genentech Inc, South San Francisco, CA.
Blood ; 133(26): 2765-2775, 2019 06 27.
Article en En | MEDLINE | ID: mdl-30862645
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Túnez
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Clinical_trials Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2019 Tipo del documento: Article País de afiliación: Túnez